Sionna Therapeutics, Inc. · NASDAQ:SION
McKee Charlotte received 50,000 Sionna Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 17, 2026 · Filed Sep 18, 2026
On Sep 17, 2026, McKee Charlotte (CMO and Head of R&D) received 50,000 Sionna Therapeutics, Inc. shares as an award, leaving 128,415 shares. Filed Sep 18, 2026 (Form 4).
- Awarded
- 50,000 shares
- Holding after
- 128,415 shares
- Trading plan
- No
- Role
- CMO and Head of R&D
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Common Stock | Award | 50,000 | 128,415 | Direct |
Source
Related
- Sionna Therapeutics, Inc.
- McKee Charlotte
- Sionna Therapeutics, Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 21, 2026
- Form 4 · Ridloff Elena · Sep 18, 2026
- Form 4 · Fitzpatrick Jennifer · Sep 18, 2026
- Form 4 · Cloonan Michael · Sep 18, 2026